RHOA and pancreatic ductal adenocarcinoma: Interestingly, Dittert et al. [26] revealed that RhoA expression in ductal pancreatic adenocarcinoma does not correlate with TNM classification, and that over-expression of this protein is strongly associated with a better prognosis.